Home › Trial NCT06349278
Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX
- Trial IDNCT06349278
- StatusRecruiting
- PhaseN/A
- Study typeInterventional
- SponsorLaval University
- Enrollment15
- Start date2024-01-16
- ConditionsPancreas Adenocarcinoma · Pancreas Metastases · Pancreas Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.